Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R Branche(University of Rochester), Kuleni Abebe(Family Health International 360), Cecilia Losada(Emory University), Martín Bäcker(Long Island University), Lilly Cheng Immergluck, Satoshi Kamidani(Emory University), Emmanuel B. Walter(Duke University), Siham Mahgoub(Howard University Hospital), David Diemert(George Washington University), Christine M. Posavad(Fred Hutch Cancer Center), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Hana M. El Sahly(Baylor College of Medicine), Paul Goepfert(University of Maryland, Baltimore), Getahun Abate(Saint Louis University), Jeffrey Bethony(George Washington University), Susan J. Little(University of California San Diego), Megan A Meagher(Fred Hutch Cancer Center), Laura Porterfield(The University of Texas Medical Branch at Galveston), Benjamin G Ladner(University of Illinois Chicago), Zacharoula Oikonomopoulou(Saint Louis University), Nadine Rouphael(Emory University), Rachel M. Presti(Johns Hopkins University), Hady Samaha(Emory University), Jennifer A. Whitaker(Baylor College of Medicine), Thomas Martin(University of California San Diego), Patricia Winokur(University of Iowa), Amy C Sherman(Dana-Farber Cancer Institute), Kathleen M. Neuzil(Center for Global Development), Richard Rupp(The University of Texas Medical Branch at Galveston), Anna Wald(University of Washington), Dahlene N. Fusco(Tulane University), Angelica C Kottkamp(New York University), Kirsten E. Lyke(University of Maryland, Baltimore), David S. Stephens(Emory University), Mark J. Mulligan(New York University), Daniel S. Graciaa(Emory University), Michael J. Smith(Duke University), Maya Dunstan(Kaiser Permanente Washington Health Research Institute), Sharon E. Frey(St. Louis VA Medical Center), Edward E. Walsh(University of Rochester), Evan J. Anderson(Emory University), Elissa Malkin(George Washington University), Anne F. Luetkemeyer(University of California, San Francisco), Ann R. Falsey(University of Rochester), Lindsey R. Baden(Brigham and Women's Hospital), Richard M. Novak(Northwestern University), Tara M Babu(Seattle Pacific University), Tamia Davis(Manhattan Psychiatric Center), Robert L. Atmar(Baylor College of Medicine)
Cited by 56
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k